The therapeutic group "Anti-anemic, Iron With Folic Acid" encompasses a class of pharmaceuticals designed to address anemia, a condition marked by a deficiency in red blood cells or hemoglobin. This group typically includes medications that combine iron and folic acid, crucial nutrients essential for the production of healthy red blood cells and the prevention of neural tube defects in pregnant women. By replenishing iron stores and supporting the synthesis of red blood cells, these medications aim to improve the oxygen-carrying capacity of the blood, alleviate symptoms of anemia such as fatigue and weakness, and promote overall wellness and vitality.